Affiliation:
1. National Medical Research Centre for Children's Health
Abstract
Current COVID-19 pandemic demands improvements in antiviral prophylaxis. Tyloron, as biological interferon activator, has been synthesized in the 70th of previous century. We used Tyloron in 60 patients – relatives and partners living together with solid organ transplant recipients – in autumn 2020, during second wave of the SARS-CoV‑2 pandemic. Results were compared with 60 patients used other means of antiviral prophylaxis. In patients taking Tyloron the number of febrile episodes was significantly lower (р < 0.02).
Subject
Materials Chemistry,Economics and Econometrics,Media Technology,Forestry
Reference5 articles.
1. Krueger R. F., Mayer G. D. Tilorone hydrochloride: an orally active antiviral agent (англ.). Science: journal. 1970. September (Vol. 169, No. 951). P. 1213–1214. PMID 4317923.
2. Mayer G. D., Krueger R. F. Tilorone hydrochloride: mode of action (англ.). Science. 1970. September (Vol. 169, No. 951). P. 1214–1215. PMID 4317924.
3. Kaufman H. E., Centifanto Y. M., Ellison E. D., Brown D. C. Tilorone hydrochloride: human toxicity and interferon stimulation (англ.). Proc Soc Exp Biol Med (англ.) русск.: journal. 1971. Vol. 137, No. 1. P. 357–560. PMID 5581674.
4. Ermol'eva Z.V., Korneeva L. E., Balezina G. I., Nikolaeva O. V., Gvazava I. S. Tilorone as an interferon inducer (неопр.). Antibiotiki. 1973. V. 18, Т. 6. P. 517–520. PMID 4204946.
5. Litvinova L. A., Bogatsky A. V., Gren A. I., Lempart G. V. On the synthesis of 2,7-bis-[2-(diethylamino)ethoxy]fluorenone‑9 (Russian). Reports of the Academy of Sciences of the Ukrainian SSR: journal. 1976. No. 7. P. 610–612.